Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padraig Warde

Showing results (21-30 of 192) with videos related to

Pageof 20
Sort By:
Cancer|November 26, 2008
Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgeryShabbir M H Alibhai, Marc Leach, Padraig Warde
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Response to "Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects" (Int J Radiat Oncol Biol Phys 2009; in press)John Thoms, Robert Bristow, Padraig Warde, et al.
Current Opinion in Urology|November 13, 2021
Management of stage I testicular cancerJerusha Padayachee, Roderick Clark, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2004
Re: Vikram, B., The PSA conundrum. [Radiother Oncol, 2004. 71(1): p. 1-2]Kirsty Wiltshire, Robert G Bristow, Padraig Warde, et al.
International Journal of Health Care Quality Assurance|November 25, 2014
IMRT utilization in Ontario: qualitative deployment evaluationKate Bak, Elizabeth Murray, Eric Gutierrez, et al.
The Canadian Journal of Urology|May 16, 2002
Survey of radiation oncologists: practice patterns of the management of stage I seminoma of testis in Canada and a selected group in the United StatesRichard Choo, Howard Sandler, Padraig Warde, et al.
Practical Radiation Oncology|January 8, 2018
Testicular seminoma: Scattered radiation dose to the contralateral testis in the modern eraHester Lieng, Peter Chung, Tony Lam, et al.
The Canadian Journal of Urology|March 7, 2006
GU radiation oncologists consensus on bone loss from androgen deprivationGraeme G Duncan, Tom Corbett, Himu Lukka, et al.
European Urology Focus|May 27, 2019
Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred OptionRobert J Hamilton, Michael A S Jewett, Padraig Warde, et al.
BJU International|September 3, 2011
Information needs of men on androgen deprivation therapyTony Soeyonggo, Padraig Warde, Neil Fleshner, et al.
Pageof 20

Showing results (21-30 of 192) with videos related to

Sort By:
Pageof 20
Cancer|November 26, 2008
Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgeryShabbir M H Alibhai, Marc Leach, Padraig Warde
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Response to "Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects" (Int J Radiat Oncol Biol Phys 2009; in press)John Thoms, Robert Bristow, Padraig Warde, et al.
Current Opinion in Urology|November 13, 2021
Management of stage I testicular cancerJerusha Padayachee, Roderick Clark, Padraig Warde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2004
Re: Vikram, B., The PSA conundrum. [Radiother Oncol, 2004. 71(1): p. 1-2]Kirsty Wiltshire, Robert G Bristow, Padraig Warde, et al.
International Journal of Health Care Quality Assurance|November 25, 2014
IMRT utilization in Ontario: qualitative deployment evaluationKate Bak, Elizabeth Murray, Eric Gutierrez, et al.
The Canadian Journal of Urology|May 16, 2002
Survey of radiation oncologists: practice patterns of the management of stage I seminoma of testis in Canada and a selected group in the United StatesRichard Choo, Howard Sandler, Padraig Warde, et al.
Practical Radiation Oncology|January 8, 2018
Testicular seminoma: Scattered radiation dose to the contralateral testis in the modern eraHester Lieng, Peter Chung, Tony Lam, et al.
The Canadian Journal of Urology|March 7, 2006
GU radiation oncologists consensus on bone loss from androgen deprivationGraeme G Duncan, Tom Corbett, Himu Lukka, et al.
European Urology Focus|May 27, 2019
Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred OptionRobert J Hamilton, Michael A S Jewett, Padraig Warde, et al.
BJU International|September 3, 2011
Information needs of men on androgen deprivation therapyTony Soeyonggo, Padraig Warde, Neil Fleshner, et al.
Pageof 20